GLP-1s May Increase Risk Of Osteoporosis And Gout By iHeartRadio March 2, 2026 Popular weight-loss and diabetes drugs known as glucagon-like peptide-1 receptor agonists (GLP-1s) may raise the risk of osteoporosis and gout, according to new research presented Monday (March 2) at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans, Louisiana
Practical Packing Checklist and Emergency Planning Create a travel medication kit containing: (1) your semaglutide pen or vial in an insulated cooler with ice packs, (2) alcohol prep pads and sterile syringes if using a vial, (3) original pharmacy-labeled prescription containers, (4) a doctor's letter confirming medical necessity, (5) copies of your prescription, (6) your PlexusDx account information or provider contact details for reference, and (7) a backup supply if your flight duration or layovers exceed your planned dose schedule
Frequently Asked Questions How much weight can you lose on retatrutide
As noted, nearly half of patients stop taking GLP-1s within the first year, often due to side effects, cost concerns, or the burden of weekly injections
